A detailed history of United Capital Management Of Ks, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, United Capital Management Of Ks, Inc. holds 42,352 shares of ABT stock, worth $4.4 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
42,352
Previous 41,158 2.9%
Holding current value
$4.4 Million
Previous $4.53 Million 6.25%
% of portfolio
1.16%
Previous 1.37%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$109.52 - $120.96 $130,766 - $144,426
1,194 Added 2.9%
42,352 $4.81 Million
Q4 2023

Jan 25, 2024

BUY
$90.19 - $110.4 $203,739 - $249,393
2,259 Added 5.81%
41,158 $4.53 Million
Q3 2023

Nov 03, 2023

BUY
$95.53 - $114.62 $40,695 - $48,828
426 Added 1.11%
38,899 $3.77 Million
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $10,279 - $11,453
102 Added 0.27%
38,473 $4.19 Million
Q1 2023

Apr 27, 2023

BUY
$96.86 - $114.01 $52,982 - $62,363
547 Added 1.45%
38,371 $3.89 Million
Q4 2022

Jan 31, 2023

BUY
$95.06 - $111.52 $107,322 - $125,906
1,129 Added 3.08%
37,824 $4.15 Million
Q3 2022

Oct 31, 2022

BUY
$96.76 - $112.03 $71,602 - $82,902
740 Added 2.06%
36,695 $3.55 Million
Q2 2022

Aug 04, 2022

BUY
$102.07 - $123.37 $90,842 - $109,799
890 Added 2.54%
35,955 $3.91 Million
Q1 2022

Apr 26, 2022

BUY
$114.02 - $139.04 $145,261 - $177,136
1,274 Added 3.77%
35,065 $4.15 Million
Q4 2021

Jan 18, 2022

BUY
$115.53 - $141.46 $130,202 - $159,425
1,127 Added 3.45%
33,791 $4.76 Million
Q3 2021

Oct 27, 2021

BUY
$116.66 - $129.06 $5,133 - $5,678
44 Added 0.13%
32,664 $3.86 Million
Q2 2021

Jul 26, 2021

BUY
$105.79 - $124.53 $116,474 - $137,107
1,101 Added 3.49%
32,620 $3.78 Million
Q1 2021

Apr 27, 2021

BUY
$108.84 - $128.23 $64,324 - $75,783
591 Added 1.91%
31,519 $3.76 Million
Q4 2020

Jan 21, 2021

BUY
$105.0 - $114.42 $166,740 - $181,698
1,588 Added 5.41%
30,928 $3.39 Million
Q3 2020

Oct 19, 2020

BUY
$91.64 - $111.29 $112,992 - $137,220
1,233 Added 4.39%
29,340 $3.19 Million
Q2 2020

Jul 17, 2020

BUY
$76.57 - $98.0 $514,244 - $658,168
6,716 Added 31.4%
28,107 $2.57 Million
Q1 2020

May 04, 2020

BUY
$62.82 - $91.86 $167,478 - $244,898
2,666 Added 14.24%
21,391 $1.69 Million
Q4 2019

Jan 24, 2020

BUY
$78.51 - $87.4 $137,235 - $152,775
1,748 Added 10.3%
18,725 $1.63 Million
Q3 2019

Oct 15, 2019

BUY
$81.84 - $88.74 $17,431 - $18,901
213 Added 1.27%
16,977 $1.38 Million
Q2 2019

Jul 25, 2019

BUY
$72.88 - $85.0 $54,805 - $63,920
752 Added 4.7%
16,764 $1.42 Million
Q1 2019

May 01, 2019

BUY
$66.22 - $80.06 $39,467 - $47,715
596 Added 3.87%
16,012 $1.23 Million
Q4 2018

Jan 10, 2019

BUY
$65.56 - $74.27 $15,603 - $17,676
238 Added 1.57%
15,416 $1.12 Million
Q3 2018

Oct 09, 2018

BUY
$60.81 - $73.36 $922,974 - $1.11 Million
15,178 New
15,178 $1.04 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track United Capital Management Of Ks, Inc. Portfolio

Follow United Capital Management Of Ks, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.